OXY Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Not a good buy right now. OXY is technically strong but short-term looks stretched (RSI ~75) with limited immediate upside to nearby resistance ($46.13/$47.28) and weakening YoY fundamentals (2025/Q3 revenue, EPS, and net income down). Options positioning is mildly bullish (put/call < 1) but not aggressive on volume, and Wall Street remains largely Neutral/Equal Weight with price targets clustering near the current price. For an impatient buyer, the risk/reward at ~$45.18 pre-market is not attractive enough to chase—better to wait for a pullback toward ~$44/$42 support or a clearer post-earnings setup.
Trend is bullish: SMA_5 > SMA_20 > SMA_200 confirms an uptrend, and MACD histogram (+0.226) is above zero and expanding (positive momentum). However, RSI_6 at ~74.97 suggests the stock is near overbought, increasing the odds of a near-term pause or pullback. Key levels: Pivot $44.254 (important near-term line), resistance at R1 $46.125 then R2 $47.28; support at S1 $42.384 then S2 $41.228. With price ~$45.18 pre-market (down -0.52%), the stock sits between pivot and R1—more room for mean reversion than a clean breakout unless oil sentiment improves materially. Pattern-based projection provided also leans negative over 1 month (-4.83%), reinforcing that this is not an optimal “buy now” moment for a quick-entry investor.
• Influential-holder support: Berkshire Hathaway’s large OXY position (news cites ~ $12B value) continues to be a sentiment backstop and can attract dip buyers.
• Momentum setup: Bullish moving-average stack and positive MACD support trend continuation if energy tape strengthens.
• Event catalyst ahead: Earnings on 2026-02-18 (after hours) can reset expectations if realized pricing/costs surprise positively.
• Options sentiment: Put/call below 1 suggests the market is slightly positioned for upside rather than protection.
raises pullback risk for anyone buying immediately.
Latest reported quarter: 2025/Q3. Growth trends were negative YoY: Revenue $6.624B (-7.65% YoY), Net Income $657M (-31.49% YoY), EPS $0.65 (-33.67% YoY), Gross Margin 32.62% (-14.72% YoY). This points to margin and earnings pressure versus last year—important because OXY’s near-term stock performance is highly sensitive to realized commodity pricing and cost discipline. Next earnings: QDEC 2025 on 2026-02-18 (After Hours), EPS est. ~0.21.
Recent trend: Mostly Neutral/Equal Weight with modest price-target tweaks and a few cuts, reflecting a cautious stance on oil-driven cash flows. Notable changes: Piper Sandler raised PT to $47 (Neutral); BofA raised PT to $45 (Neutral); Susquehanna cut PT to $51 (Positive); Morgan Stanley cut to $50 (Equal Weight); Barclays reinstated $50 (Equal Weight); JPMorgan cut to $42 (Underweight). Wall Street pros: debt reduction/divestiture progress and leverage to energy strength; cons: commodity-cycle exposure, oversupply concerns, and the loss of some cash-flow insulation post-divestiture. Net takeaway: the Street is not positioned as if a large upside rerating is imminent from ~$45. Politicians/congress: No recent congress trading data provided. Influential figures: Berkshire Hathaway’s large stake remains a positive sentiment factor.
